Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac arrest, Echocardiogram
Clinical narrative: she had 3rd dose of vaccine and under 24 hours later she went into cardiac arrest; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC ARREST (she had 3rd dose of vaccine and under 24 hours later she went into cardiac arrest) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048F20A, 031L20A and 012L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020 and Cardiomyopathy. Concurrent medical conditions included Blood pressure high (Medication to lower blood pressure), Inflammation and Heart rate abnormal. Concomitant products included CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) for Inflammation, VITAMIN D NOS for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2021, the patient experienced CARDIAC ARREST (she had 3rd dose of vaccine and under 24 hours later she went into cardiac arrest) (seriousness criteria medically significant and life threatening). At the time of the report, CARDIAC ARREST (she had 3rd dose of vaccine and under 24 hours later she went into cardiac arrest) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Echocardiogram: nothing was pre-existing nothing was pre-existing.         Patient stated that she felt she was dragging for several months but felt fine by time she was due for 3rd dose.  Other concomitant medications included medication to lower blood pressure and heart rate. Stated prior to cardiac event after 3rd dose she was not on medications.  It was reported that from the last echocardiogram she had it was determined that nothing was pre-existing and there was correlation to the vaccine. During echocardiogram she had been given a contrast and had a reaction and her HCP stated this ingredient in the contrast was also in the vaccine PEG.  Treatment included medication to lower pressure and heart rate.   This case was linked to MOD-2022-460508 (Patient Link).; Sender's Comments: This is a spontaneous case concerns a 58-year-old female patient with relevant medical history of cardiomyopathy and current condition of hypertension, inflammation and heart rate abnormal, who experienced the serious unexpected life-threatening event of cardiac arrest. The event occurred less than 24 hours after the third dose of mRNA-1273 vaccine administration. The event was considered as related to the product administration per temporal association. The rechallenge was not applicable since the event occurred after the third mRNA-1273 dose and no further dosing is expected. The multi-morbid cardiovascular medical history considered as a confounder. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Additional information has been requested.